Taiwan-based Advanced Genomics APAC Co. has announced the signing of an exclusive service provider agreement with Cancer...
The World Health Organization (WHO) has prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6...
CBC Group's R-Bridge Healthcare Fund has announced $40 million structured financing transaction with Mirxes, a...
Revvity, Inc. has received 510(k) clearance from the US Food and Drug Administration (FDA) for EUROIMMUN’s au...
Japan-based NEC Corporation and Biomy, Inc. have signed a Memorandum of Understanding (MoU) for a joint market...
Taiwan-based startup Primo Biotechnology has announced a strategic partnership with US-based SHINE Technologies, LLC, a ...
The global leader in eye care for over 75 years, Alcon strives to help eye care professionals strengthen their practices...
Fujirebio Holdings, a wholly-owned subsidiary of H.U. Group Holdings, Inc., and Eisai Co., in Japan, have entered into a...
The World Health Organization (WHO) has granted prequalification to the molecular diagnostic test for tuberculosis (TB) ...
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, has announced i...
US-based GE HealthCare has announced its work with Peter MacCallum Cancer Centre in Australia to further develop and exp...
Newbase, a leader in metaverse-based medical education platforms, has announced the launch of its new product, 'Medicrew...
Neurophet, an artificial intelligence (AI) solution company for brain disease, has announced that its brain MRI analysis...
King Faisal Specialist Hospital & Research Centre (KFSHRC) has unveiled its state-of-the-art Virtual Pathology Servi...
South Korea-based Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and...
SpaceGut, part of SOL Partnership Sdn Bhd, has introduced Malaysia's first artificial intelligence (AI)-p...
• The largest edition yet, nearly double the size of the 2023 edition.• Hall A1 fully booked six months in adv...
Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 578 mi...
